Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE American:OGEN)

0.1694
Delayed Data
As of 3:59pm ET
 -0.0007 / -0.41%
Today’s Change
0.06
Today|||52-Week Range
0.85
-27.88%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.17
Today’s open0.18
Day’s range0.15 - 0.18
Volume273,007
Average volume (3 months)176,078
Market cap$8.4M
Data as of 3:59pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+40.69%
Earnings growth (this year)-21.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc0.000.00%
CBIOCatalyst Biosciences...-0.95-6.28%
KZIAKazia Therapeutics L...+0.25+8.69%
ANTHAnthera Pharmaceutic...-0.03-2.22%
Data as of 4:00pm ET, 01/16/2018

Financials

Last reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts